ADVENT CAPITAL MANAGEMENT /DE/ - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVENT CAPITAL MANAGEMENT /DE/ ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2018$19,000
-100.0%
18,000
-100.0%
0.00%
-100.0%
Q2 2018$43,996,000
-27.5%
41,234,000
-30.2%
0.93%
-22.3%
Q1 2018$60,714,000
-12.3%
59,076,000
-7.6%
1.19%
-10.2%
Q4 2017$69,268,000
-13.4%
63,930,000
-10.7%
1.33%
-12.4%
Q3 2017$79,987,000
+4.8%
71,592,000
+4.4%
1.52%
+3.8%
Q2 2017$76,305,000
+3.6%
68,589,000
+5.9%
1.46%
+6.0%
Q1 2017$73,667,000
+16.5%
64,770,000
+15.5%
1.38%
+18.4%
Q4 2016$63,226,000
+24.7%
56,067,000
+32.7%
1.16%
+58.8%
Q3 2016$50,719,000
+12.5%
42,248,000
+4.3%
0.73%
+5.0%
Q2 2016$45,097,000
-16.3%
40,514,000
-13.0%
0.70%
-15.2%
Q1 2016$53,895,000
-19.3%
46,556,000
-9.4%
0.82%
-19.9%
Q4 2015$66,747,000
-0.1%
51,401,000
+0.7%
1.03%
+0.6%
Q3 2015$66,798,000
+9.0%
51,055,000
+29.5%
1.02%
+15.9%
Q2 2015$61,272,000
+1.5%
39,435,000
-3.7%
0.88%
+1.0%
Q1 2015$60,367,000
-14.2%
40,940,000
-31.4%
0.87%
-15.7%
Q4 2014$70,392,000
+5.6%
59,647,000
-4.9%
1.03%
+0.7%
Q3 2014$66,638,000
-2.1%
62,750,000
-2.6%
1.03%
+1.1%
Q2 2014$68,092,000
+67.2%
64,416,000
+73.4%
1.02%
+59.7%
Q1 2014$40,718,000
-3.7%
37,155,000
-6.4%
0.64%
+19.5%
Q4 2013$42,286,00039,691,0000.53%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2014
NameSharesValueWeighting ↓
MACKAY SHIELDS LLC 25,176,000$27,679,0001.40%
ADVENT CAPITAL MANAGEMENT /DE/ 37,155,000$40,718,0000.64%
OAKTREE CAPITAL MANAGEMENT LP 24,250,000$26,747,0000.50%
Jabre Capital Partners S.A. 3,500,000$3,838,0000.37%
Calamos Advisors LLC 40,441,000$44,067,0000.28%
Calamos Wealth Management LLC 669,000$729,0000.22%
Baker Brothers Advisors 12,500,000$13,699,0000.17%
PALISADE CAPITAL MANAGEMENT, LP 5,024,000$5,508,0000.14%
SSI INVESTMENT MANAGEMENT LLC 1,127,000$1,236,0000.13%
Compagnie Lombard Odier SCmA 1,300,000$1,423,0000.06%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders